FDA Approved: XELPROS — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves XELPROS (latanoprost) from Sun Pharmaceutical as a new ophthalmic solution for lowering intraocular pressure in open-angle glaucoma or ocular hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• XELPROS (LATANOPROST)

Snippet

ORIG AP for XELPROS (LATANOPROST)